Type 2 diabetes itself confers increased thrombotic risk through multiple mechanisms, including hyperglycaemia-induced endothelial damage, increased platelet reactivity, elevated coagulation factors, and reduced fibrinolysis
Impact of metformin use and diabetic status during adjuvant fluoropyrimidine-oxaliplatin chemotherapy on the outcome of patients with resected colon cancer: a TOSCA study subanalysis
Heres the critical distinction that many people miss: FDA approval determines what a drug company can market and advertise a medication for
If you don't have diabetes and you have hypoglycemia, your provider will likely order other tests to try to figure out the cause
These mechanisms of action make semaglutide an effective treatment option for individuals with insulin resistance who are struggling with weight management
The effects are also cumulative, meaning consistent treatments often provide greater long-term results